ResearchMoz

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

GlobalData
Published Date » 2014-06-20
No. Of Pages » 159
   
 Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and...
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bipolar Disorder (Manic Depression) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bipolar Disorder (Manic Depression) 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 38
Mar 31, 2014: Forest Laboratories and Gedeon Richter Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment of Bipolar Depression 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Abbott Laboratories 58
Clinical Trial Overview of Abbott Laboratories 58
Merck & Co., Inc. 60
Clinical Trial Overview of Merck & Co., Inc. 60
Bristol-Myers Squibb Company 62
Clinical Trial Overview of Bristol-Myers Squibb Company 62
Novartis AG 64
Clinical Trial Overview of Novartis AG 64
Clinical Trial Overview of Top Institutes / Government 66
National Institute of Mental Health 66
Clinical Trial Overview of National Institute of Mental Health 66
Massachusetts General Hospital 69
Clinical Trial Overview of Massachusetts General Hospital 69
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
U.S. Department of Veterans Affairs 73
Clinical Trial Overview of U.S. Department of Veterans Affairs 73
Mclean Hospital 74
Clinical Trial Overview of Mclean Hospital 74
University of Texas Southwestern Medical Center at Dallas 75
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 75
University of Cincinnati 76
Clinical Trial Overview of University of Cincinnati 76
University of British Columbia 77
Clinical Trial Overview of University of British Columbia 77
University Hospitals of Cleveland 78
Clinical Trial Overview of University Hospitals of Cleveland 78
Lindner Center of HOPE 79
Clinical Trial Overview of Lindner Center of HOPE 79
Five Key Clinical Profiles 80

Appendix 157
Abbreviations 157
Definitions 157
Research Methodology 158
Secondary Research 158
About GlobalData 159
Contact Us 159
Disclaimer 159
Source 159

List of Tables


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bipolar Disorder (Manic Depression) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bipolar Disorder (Manic Depression) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 50
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 53
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 56
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 58
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 60
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 62
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 64
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 66
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 69
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 72
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 73
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 74
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 75
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 76
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 77
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2014* 78
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lindner Center of HOPE, 2014* 79

List of Figures


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 158

Upcoming Reports:

Rheumatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
With increasing joint and connective tissue problems caused by hectic lifestyles, non-nutritious food habits, and lack of physical workouts, the demand for rheumatology is on an increase on a global scale. Rheumatology is concerned with the therapy of rheumatic diseases and problems involving joints, soft tissues, autoimmune diseases, heritable connective tissue disorders, and vasculitis. Some of the major rheumatic conditions are neck pain, back pain, osteoarthritis, and bursitis. From 2005 to 2011, the rheumatology therapeutics market has grown at an encouraging rate, but during the...
Hysterectomy Alternatives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Hysterectomy is the process where complete or partial uterus is removed from the women’s body by the gynecologist. In complete uterus removal, fundus, cervix and body of the uterus are removed whereas in partial only body of the uterus is excised.Hysterectomy is performed when a women is suffering from fibroids, uterine prolapse, endometriosis, chronic pelvic pain, vaginal bleeding and cancer of uterus, ovaries and cervix. It has been observed in U.S. that 1 out of 3 women are undergoing hysterectomy annually. Hysterectomy has various issues such as hormonal imbalance,...
Low Emission Vehicle Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
A hybrid vehicle is the combination of traditional engines and electric vehicles. They use features of both traditional and electric systems to reduce the emission levels of gases. Traditional engines, which run on fuels such as diesel and gasoline, are scarce and they emit a variety of gases such as carbon dioxide, carbon monoxide, etc. Currently, the market is dominated by traditional engine based vehicles with several manufacturers and suppliers, which has resulted in faster consumption of fossil fuels and increased emission levels. Regulatory bodies and auto manufacturers are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Brand New Flagship Sedan to be Unveiled by Cadillac March 31
Jan 23, 2015  
According to sources in Cadillac, the company is all set to reveal its large flagship CT6 sedan March 31. The sources revealed further that the company has already made an investment of $300 million in its plant at Detroit-Hamtramck to start building the vehicle. General Motors Co said that advanced technique of mixed-material manufacturing will be used for the new vehicle that is...
North Korea Looks to Hire English-speakers to Educate Tourist Guides
Jan 23, 2015  
English-speaking individuals can now get a chance to look behind the Iron Curtain of the most secretive nation in the world. According to a new program introduced by North Korea, foreigners will be employed to provide English-speaking training to local tourist guides.  Over the course of a month, these foreign specialists at the Pyongyang Tourism College will teach the guides...
Barrack Obama Wants to See a Rise in Number of Indian Tourists in America
Jan 23, 2015  
President of the United States of America Barrack Obama, accompanied by his wife Michelle are on their way to New Delhi, India to spend the weekend with an added excursion to the Taj Mahal in Agra. Industry experts are of the belief that this trip is most likely to see a million tourists from India to the United States in this year. Despite this, Uncle Sam wants more. A report suggests...
Approximately US$18.4 Billion Spent in US by International Tourists in Nov 2014
Jan 23, 2015  
Stefan M. Selig, Under Secretary of Commerce for International Trade announced on Thursday that a whopping US$18.4 billion was spent by international tourists in November 2014 to the United States of America. This includes tourism-related activities and money spent on travel. This number is a slight raise from those calculated in November 2013.  On an average, approximately US$615...
Toyota May Underperform as against Volkswagen in Terms of Global Sales
Jan 23, 2015  
Toyota Motor Corp., which defeated Volkswagen Group to hold the top position might lose the crown in 2015 as it is behind China’s automobile manufacturing plans.  As per Toyota’s predictions, its global deliveries will decrease 1% in the current year to 10.15 million automobiles. If put in a different way, it would result in only 10,000 units more than what the German...